#NewsSpeak: the EMA restricts daclizumab

More on daclizumab and the risk of liver toxicity. #NewsSpeak #MSBlog

Information for people with MS from the European Medicines Agency:

The safety of the multiple sclerosis medicine Zinbryta is being reviewed. As a precaution, changes have been made to the way the medicine is used while this review is ongoing:
Jaundice - yellowing of whites of the eyes and skin. 

CoI: multiple

Labels: , ,